Science and Research

CRISP / AIO-TRK-0315: Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Clinical Research Platform into Molecular Testing, Treatment, Outcome (CRISP): A Prospective German Registry in Stage IV NSCLC AIO-TRK-0315.

Study details
Study-ID: NCT02622581
Study-ID: NCT02622581
DZL Disease Area: LC
DZL Disease Area: LC
Study Type: Observational
Study Type: Observational
DZL Role: DZL recruiting center, DZL on steering board
DZL Role: DZL recruiting center, DZL on steering board
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: ARCN, CPC-M
DZL Participating Sites: ARCN, CPC-M
Start Date: 01.12.2015
Completion Date: 31.12.2027
Status: Recruiting
Status: Recruiting
DZL recruiting center, DZL on steering board
Link to Study


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.